At the Veeva Commercial Summit in Boston, leading biopharma companies like argenx, Bayer, and Gilead showcased how AI and data-driven strategies are reshaping sales, marketing, and medical engagement. The event featured over 100 sessions on new technologies such as Veeva's Agentic Commercial platform, which integrates AI and data to improve customer interactions and patient outcomes. This summit underscores the industry's push toward smarter, faster, and more compliant commercial operations to deliver better medicines to patients globally.
The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...
The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...
New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...
Aehr Test Systems is shifting its semiconductor testing business towards AI processors and data centers, driving strong growth prospects. The company reported $18.8 million in Q4 revenue, up from $14.1 million last year, and a net income turnaround t...
BlackRock reported quarterly earnings per share of $13.91, surpassing analyst estimates of $12.69, and revenue of $7.08 billion, exceeding expectations of $6.73 billion. The company’s assets under management reached a record $15.3 trillion, a 22% inc...
